Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)-Reference-Cited by-同舟云学术

Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID)

Published:2023-07-11 Issue:8 Volume:37 Page:1741-1744
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Elessa Dikelele^ORCID,Zhao Lin-Pierre^ORCID,de Oliveira Rafael Daltro,Maslah Nabih,Soret-Dulphy Juliette,Verger Emmanuelle,Marcault Clémence,Parquet Nathalie,Fenaux Pierre,Adès Lionel^ORCID,Raffoux Emmanuel,Giraudier Stéphane^ORCID,Fain Olivier,Cassinat Bruno^ORCID,Kiladjian Jean-Jacques,Mekinian Arsene^ORCID,Benajiba Lina^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-023-01967-0.pdf

Reference16 articles.

1. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia. 2022;36:1703–19.

2. Grinfeld J, Nangalia J, Baxter EJ, Wedge DC, Angelopoulos N, Cantrill R, et al. Classification and personalized prognosis in myeloproliferative neoplasms. NEJM. 2018;379:1416–30.

3. Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. NEJM. 2020;27:2628–38.

4. Barcellini W, Fattizzo B. Immune phenomena in myeloid neoplasms: an “egg or chicken” question. Front Immunol. 2021;12:751630.

5. Marcault C, Zhao L-P, Maslah N, Verger E, Daltro de Oliveira R, Soret-Dulphy J, et al. Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms. Blood. 2021;138:2142–8.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression;Life;2024-02-27